Yarbrough Capital, LLC Veracyte, Inc. Transaction History

Yarbrough Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	BUY	$15.31 - $29.94 $149,976 - $293,292	9,796 New	9,796 $0
Q2 2022 Jul 08, 2022	SELL	$15.45 - $29.52 $182,881 - $349,428	-11,837 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$21.94 - $42.51 $44,779 - $86,762	2,041 Added 20.84%	11,837 $326,000
Q4 2021 Feb 01, 2022	BUY	$36.09 - $53.79 $353,537 - $526,926	9,796 New	9,796 $404,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Yarbrough Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Yarbrough Capital, LLC with notifications on news.